Patient Oxygenator Articles & Analysis
20 news found
Why is the oxygen generator important? Oxygen is a life-saving therapeutic gas, which is often used to treat patients with severe pneumonia and other respiratory diseases. Oxygen generator is an electric medical equipment. It first inhales air, removes nitrogen, then generates a continuous oxygen source, and ...
SPRINTER (SG018; NCT04732949) was a global, randomised, placebo-controlled, double-blind clinical trial assessing the efficacy and safety of inhaled SNG001 for the treatment of adults hospitalised due to COVID-19 who required treatment withsupplemental oxygen. The trial recruited a total of 623 patients who were randomised to receive SNG001 (n=309) or placebo ...
ECCMID 2022: Oral Presentation: Title: Effects of Inhaled interferon beta on hospitalised COVID-19 patients receiving supplemental oxygen Abstract Number: 02567 Session type: 1-Hour Mini-oral Flash Session Session name: COVID-19 treatment insights and advances Session date and time: 23 April 2022 at 11:00 WEST The poster presentation is now available on ...
They tell us that our light-weight mobile device has the potential to reduce patients high flow supplemental oxygen dependence, improve their mobility by allowing treatment while traveling and at home, and reduce the risk of heart failure by lowering pulmonary hypertension. These benefits may allow patients to live higher quality lives, require ...
The IPV (Inflatable Prone Ventilation) support consists of inflatable pelvic and thoracic pillows allowing the patient to lie in a prone position with a free hanging abdomen. Prone ventilation allows for better oxygenation and thus maximum lung ventilation and oxygen absorption in the patient’s blood. The unique selling ...
The new publication highlights 52 critically ill COVID-19 patients from 5 major U.S. ECMO (ExtraCorporeal Membrane Oxygenation) centers who received ECMO plus CytoSorb therapy for life-threatening refractory respiratory failure under FDA EUA between April 2020 and April 2021.1 As highlighted in topline results that were previously presented at the 40th ...
IPF is a chronic and ultimately fatal disease that causes lung tissue to stiffen, leading to permanent lung scarring that makes it harder to breathe. As IPF progresses, patients often need oxygen and, in some cases, lung transplantation. With a median survival of ∼3 years, the prognosis can be devastating, and there is a clear unmet need for better ...
(NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, announced today that the Company will present at H.C. ...
ByCervoMed
In order to demonstrate benefit over risk, ALung submitted data to FDA from over 1,000 Hemolung patient treatments on clinical safety and over 230 Hemolung patient treatments on clinical performance outcomes. ...
To celebrate two centuries of care, the MGH is pleased to introduce other “first patients.” Here are their stories . . Patient Pioneer: The Story of Courtney Joyce – the first MGH patient to benefit from inhaled nitric oxide (NO) as a therapy for cystic fibrosis. ...
The AGM100 provides clinicians with a full picture of patient blood oxygen and gas exchange levels right at the bedside without requiring any blood draws or needle sticks, which helps prevent problems like infection in low resource settings. ...
"Interestingly, when you reintroduce the blood flow, there's a the second wave of cell death, as the oxygen streaming into the cells can no longer be processed by the impaired mitochondria. ...
(“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announces enrollment of patients for its study entitled “A Phase II, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With ...
Food and Drug Administration (FDA) for use in hospitalised COVID-19 patients who require supplemental oxygen or invasive mechanical ventilation. ...
Key Findings of Primary Analysis: Every patient used less oxygen when using VOCSN compared to when using HT70. Using 30 “average” patients with 24-hour oxygen requirements for 31 days: Patients using VOCSN used 75% less oxygen compared to patients using HT70. ...
In less than two minutes, it allows doctors to assess how well a patient’s lungs are taking oxygen from the air through their lungs into the bloodstream,” says Dr. ...
AVM has FDA permission to begin clinical trials using AVM0703 to treat patients with COVID-19- and influenza-mediated Acute Respiratory Distress Syndrome (ARDS). ...
Pune: Technology startup Nocca Robotics has launched a high flow oxygen therapy (HFOT) device, which has a greater demand than invasive ventilators for treating fairly critical Covid-19 patients. ...
The data include changes in oxygen, comparison of current patient’s data with historical data from a clinical registry study, and a data report. ...
The hydrogel is linked to light-emitting fluorescent molecules that continuously signal in proportion to the concentration of a body chemical, such as oxygen, glucose, or other biomolecule of interest. Smaller than a grain of rice, Profusa’s implantable biosensors can continuously measure body chemistries such as oxygen and glucose, and is designed to ...